Home / Business / Business News / FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

June 03, 2023 Business, Business News

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.

from Business News https://ift.tt/dZ4ThNk
via IFTTT https://ift.tt/XbyZOgY

No comments

Subscribe to: Post Comments ( Atom )